Clinical Trial Update: A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma [Phase 3]

View source ↗

Summary

A Phase III trial evaluating Marizomib in patients with newly diagnosed glioblastoma has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Marizomib (marizomib)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Newly Diagnosed Glioblastoma | Phase 3 | Status: COMPLETED | Results posted: 2024-01-31